The Advances of Neutrophil-Derived Effective Drug Delivery Systems: A Key Review of Managing Tumors and Inflammation

Huaiji Wang,1 Jie Zang,2 Zihan Zhao,3 Qin Zhang,1 Shunjie Chen1 1Department of Nephrology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of China; 2The Institute for Biomedical Engineering & Nano Science, School of Medicine, Tongji Universi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wang H, Zang J, Zhao Z, Zhang Q, Chen S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/d644fd62d9f341e08410ebca7d0a2b8d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d644fd62d9f341e08410ebca7d0a2b8d
record_format dspace
spelling oai:doaj.org-article:d644fd62d9f341e08410ebca7d0a2b8d2021-12-02T18:43:43ZThe Advances of Neutrophil-Derived Effective Drug Delivery Systems: A Key Review of Managing Tumors and Inflammation1178-2013https://doaj.org/article/d644fd62d9f341e08410ebca7d0a2b8d2021-11-01T00:00:00Zhttps://www.dovepress.com/the-advances-of-neutrophil-derived-effective-drug-delivery-systems-a-k-peer-reviewed-fulltext-article-IJNhttps://doaj.org/toc/1178-2013Huaiji Wang,1 Jie Zang,2 Zihan Zhao,3 Qin Zhang,1 Shunjie Chen1 1Department of Nephrology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of China; 2The Institute for Biomedical Engineering & Nano Science, School of Medicine, Tongji University, Shanghai, People’s Republic of China; 3Department of Dermatology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of ChinaCorrespondence: Shunjie ChenDepartment of Nephrology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of ChinaEmail chenshunjie77csj@163.comAbstract: The chimeric trait of recruitment by inflammatory signals endows neutrophils with the functionality of migrating to inflamed tissues, which can be utilized to tailor novel drug delivery systems. In this review, we introduce a mechanism of neutrophil-derived drug delivery systems recruited into inflamed sites and provide insight into tumors and inflammation therapy. In particular, the advantages of neutrophils—their endogenous-derived neutrophil membrane, exosomes as drug carriers for augmented targeting, prolonged circulation, and improved biostability—were concluded. Subsequently, the latest application in the treatment of tumors and inflammation was elaborated upon, followed by a discussion of the future prospects to neutrophil-derived delivery systems. This promising system will provide new therapeutic avenues for the treatment of inflammation and tumors.Keywords: neutrophil-derived delivery, tumors and inflammation, targeting, circulation, biostabilityWang HZang JZhao ZZhang QChen SDove Medical Pressarticleneutrophil-derived deliverytumors and inflammationtargetingcirculationbiostabilityMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 7663-7681 (2021)
institution DOAJ
collection DOAJ
language EN
topic neutrophil-derived delivery
tumors and inflammation
targeting
circulation
biostability
Medicine (General)
R5-920
spellingShingle neutrophil-derived delivery
tumors and inflammation
targeting
circulation
biostability
Medicine (General)
R5-920
Wang H
Zang J
Zhao Z
Zhang Q
Chen S
The Advances of Neutrophil-Derived Effective Drug Delivery Systems: A Key Review of Managing Tumors and Inflammation
description Huaiji Wang,1 Jie Zang,2 Zihan Zhao,3 Qin Zhang,1 Shunjie Chen1 1Department of Nephrology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of China; 2The Institute for Biomedical Engineering & Nano Science, School of Medicine, Tongji University, Shanghai, People’s Republic of China; 3Department of Dermatology, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of ChinaCorrespondence: Shunjie ChenDepartment of Nephrology, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, People’s Republic of ChinaEmail chenshunjie77csj@163.comAbstract: The chimeric trait of recruitment by inflammatory signals endows neutrophils with the functionality of migrating to inflamed tissues, which can be utilized to tailor novel drug delivery systems. In this review, we introduce a mechanism of neutrophil-derived drug delivery systems recruited into inflamed sites and provide insight into tumors and inflammation therapy. In particular, the advantages of neutrophils—their endogenous-derived neutrophil membrane, exosomes as drug carriers for augmented targeting, prolonged circulation, and improved biostability—were concluded. Subsequently, the latest application in the treatment of tumors and inflammation was elaborated upon, followed by a discussion of the future prospects to neutrophil-derived delivery systems. This promising system will provide new therapeutic avenues for the treatment of inflammation and tumors.Keywords: neutrophil-derived delivery, tumors and inflammation, targeting, circulation, biostability
format article
author Wang H
Zang J
Zhao Z
Zhang Q
Chen S
author_facet Wang H
Zang J
Zhao Z
Zhang Q
Chen S
author_sort Wang H
title The Advances of Neutrophil-Derived Effective Drug Delivery Systems: A Key Review of Managing Tumors and Inflammation
title_short The Advances of Neutrophil-Derived Effective Drug Delivery Systems: A Key Review of Managing Tumors and Inflammation
title_full The Advances of Neutrophil-Derived Effective Drug Delivery Systems: A Key Review of Managing Tumors and Inflammation
title_fullStr The Advances of Neutrophil-Derived Effective Drug Delivery Systems: A Key Review of Managing Tumors and Inflammation
title_full_unstemmed The Advances of Neutrophil-Derived Effective Drug Delivery Systems: A Key Review of Managing Tumors and Inflammation
title_sort advances of neutrophil-derived effective drug delivery systems: a key review of managing tumors and inflammation
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/d644fd62d9f341e08410ebca7d0a2b8d
work_keys_str_mv AT wangh theadvancesofneutrophilderivedeffectivedrugdeliverysystemsakeyreviewofmanagingtumorsandinflammation
AT zangj theadvancesofneutrophilderivedeffectivedrugdeliverysystemsakeyreviewofmanagingtumorsandinflammation
AT zhaoz theadvancesofneutrophilderivedeffectivedrugdeliverysystemsakeyreviewofmanagingtumorsandinflammation
AT zhangq theadvancesofneutrophilderivedeffectivedrugdeliverysystemsakeyreviewofmanagingtumorsandinflammation
AT chens theadvancesofneutrophilderivedeffectivedrugdeliverysystemsakeyreviewofmanagingtumorsandinflammation
AT wangh advancesofneutrophilderivedeffectivedrugdeliverysystemsakeyreviewofmanagingtumorsandinflammation
AT zangj advancesofneutrophilderivedeffectivedrugdeliverysystemsakeyreviewofmanagingtumorsandinflammation
AT zhaoz advancesofneutrophilderivedeffectivedrugdeliverysystemsakeyreviewofmanagingtumorsandinflammation
AT zhangq advancesofneutrophilderivedeffectivedrugdeliverysystemsakeyreviewofmanagingtumorsandinflammation
AT chens advancesofneutrophilderivedeffectivedrugdeliverysystemsakeyreviewofmanagingtumorsandinflammation
_version_ 1718377769982754816